Compare Stocks › ABBV vs ETN

AbbVie Inc. (ABBV) vs Eaton Corporation plc (ETN): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. ETN is fairly valued at $370, with an intrinsic value of $410 and a margin of safety of 10%. Of the two, ETN has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
ETN
Eaton Corporation plc
$369.97

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
ETN
  • ★Eaton Corporation plc scores 87/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Free cash flow has grown at a 22.5% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Each dollar of retained earnings has created $2.28 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
ETN
  • ⚠FCF yield of 2.2% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠PEG ratio of 2.25 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ABBV
ETN
Valuation
N/A
Free Cash Flow
$3.11B
N/A
FCF Yield
2.16%
50.67
Trailing P/E
37.64
18.24
Forward P/E
22.70
Quality & Moat
29.08%
ROIC
9.44%
N/A
ROE
19.68%
73.72%
Gross Margin
36.02%
0.60
PEG Ratio
2.25
Balance Sheet Safety
N/A
Net Debt / Equity
1.02
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
3.11
2.35%
Dividend Yield
1.19%
ABBV: 6Ties: 1ETN: 1
ABBVETN

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ETN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ETN
$9.27
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$6.59B
Δ Market Cap
+$61.12B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ETN
9.8% Margin of Safety
Price is 9.8% below estimated fair value
Current Price: $369.97
Fair Value: $409.95
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

ETN

What growth rate is the market pricing in at $370?

+16.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +21.0%

The market implies +16.9% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +21.0%, reflecting ongoing growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ETN
87/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ETN
-2.36
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ETN
Insiders 0.1%Institutions 87.8%Retail & Other 12.1%
No. of Institutional Holders3,503
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ETN
1
Buys (3M)
3
Buys (12M)
Total value (12M): $550,337
JOHNSON GERALD
Director
$92,162
@ $460.81 · 2026-08-13
JOHNSON GERALD
Director
$390,197
@ $406.03 · 2026-05-11
JOHNSON GERALD
Director
$67,978
@ $339.89 · 2025-11-18
JOHNSON GERALD
Director
$38,434
@ $384.34 · 2025-10-31
JOHNSON GERALD
Director
$36,100
@ $361.00 · 2025-08-11
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ETN
2
Sells (3M)
8
Sells (12M)
Total value (12M): $22.59M
MONESMITH HEATH B
Officer
$8.26M
@ $458.04 · 2026-08-11
WADECKI ADAM A.
Officer
$231,285
@ $440.54 · 2026-08-04
THOMPSON DOROTHY C.
Director
$64,295
@ $385.00 · 2026-05-22
GALVAO ANTONIO
Officer
$200,492
@ $405.85 · 2026-05-13
DENK PETER
Officer
$835,880
@ $417.94 · 2026-05-06
MONESMITH HEATH B
Officer
$7.51M
@ $409.11 · 2026-05-06
YELTON MICHAEL
Officer
$1.31M
@ $374.15 · 2026-03-02
RUIZ STERNADT PAULO
Officer and Director
$4.18M
@ $390.26 · 2026-02-12
LEONETTI OLIVIER C
Officer
$5.74M
@ $358.39 · 2025-08-07
THOMPSON DOROTHY C.
Director
$45,809
@ $327.21 · 2025-05-20
MONESMITH HEATH B
Officer
$3.01M
@ $330.89 · 2025-05-14
ARNOLD CRAIG
Officer and Director
$33.40M
@ $322.75 · 2025-05-12
ARNOLD CRAIG
Officer and Director
$15.59M
@ $305.43 · 2025-05-08
MARSHALL ERNEST W JR
Officer
$5.00M
@ $300.05 · 2025-05-07
YELTON MICHAEL
Officer
$629,364
@ $296.87 · 2025-05-06
DENK PETER
Officer
$392,988
@ $298.85 · 2025-05-06
PAGE GREGORY R
Director
$3.56M
@ $355.98 · 2024-12-13
MONESMITH HEATH B
Officer
$2.90M
@ $359.93 · 2024-12-09
SZMAGALA TARAS G JR.
Officer
$498,964
@ $375.73 · 2024-11-29
MARSHALL ERNEST W JR
Officer
$534,556
@ $378.58 · 2024-11-25
SZMAGALA TARAS G JR.
Officer
$490,528
@ $360.68 · 2024-11-07
ARNOLD CRAIG
Officer and Director
$22.22M
@ $360.97 · 2024-11-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ETN
FearGreed
😨Fear(40/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
ETN
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (40)
View ABBV Full AnalysisView ETN Full Analysis

Frequently Asked Questions: ABBV vs ETN

Is AbbVie Inc. or Eaton Corporation plc more undervalued in 2026?▼

Based on our discounted cash flow model, ETN trades at a 9.8% margin of safety (intrinsic value $410 vs. price $370), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Eaton Corporation plc?▼

ETN scores 87/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ETN scores 4.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Eaton Corporation plc?▼

ABBV earns 29.1% ROIC versus ETN's 9.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Eaton Corporation plc's?▼

ETN's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). ETN has raised its dividend for 3 consecutive years.

ABBV vs ETN: Which Is the Better Buy in 2026? | SafetyMargin.io